FI924575A - Nya t-cellymfom-cdna-kloner - Google Patents

Nya t-cellymfom-cdna-kloner Download PDF

Info

Publication number
FI924575A
FI924575A FI924575A FI924575A FI924575A FI 924575 A FI924575 A FI 924575A FI 924575 A FI924575 A FI 924575A FI 924575 A FI924575 A FI 924575A FI 924575 A FI924575 A FI 924575A
Authority
FI
Finland
Prior art keywords
novel
expressed
proteins
cell
dna sequences
Prior art date
Application number
FI924575A
Other languages
English (en)
Other versions
FI108037B (fi
FI924575A0 (fi
Inventor
Carol L Macleod
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of FI924575A publication Critical patent/FI924575A/fi
Publication of FI924575A0 publication Critical patent/FI924575A0/fi
Application granted granted Critical
Publication of FI108037B publication Critical patent/FI108037B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI924575A 1990-04-13 1992-10-09 Menetelmä T-lymfasoluproteiinin valmistamiseksi, menetelmässä käytettävä ilmentämisväline, vektori ja isäntäsolu FI108037B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50968490A 1990-04-13 1990-04-13
US50968490 1990-04-13
US9102518 1991-04-12
PCT/US1991/002518 WO1991016430A1 (en) 1990-04-13 1991-04-12 NOVEL T-CELL LYMPHOMA cDNA CLONES

Publications (3)

Publication Number Publication Date
FI924575A true FI924575A (fi) 1992-10-09
FI924575A0 FI924575A0 (fi) 1992-10-09
FI108037B FI108037B (fi) 2001-11-15

Family

ID=24027673

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924575A FI108037B (fi) 1990-04-13 1992-10-09 Menetelmä T-lymfasoluproteiinin valmistamiseksi, menetelmässä käytettävä ilmentämisväline, vektori ja isäntäsolu

Country Status (22)

Country Link
US (2) US5312733A (fi)
EP (1) EP0527813B1 (fi)
JP (1) JPH05506989A (fi)
KR (1) KR100212371B1 (fi)
AT (1) ATE141105T1 (fi)
AU (1) AU664535B2 (fi)
CA (1) CA2080018C (fi)
DE (1) DE69121240T2 (fi)
DK (1) DK0527813T3 (fi)
ES (1) ES2093100T3 (fi)
FI (1) FI108037B (fi)
GR (1) GR3021478T3 (fi)
HK (1) HK1006726A1 (fi)
IE (1) IE75903B1 (fi)
IL (1) IL97775A (fi)
NO (1) NO307341B1 (fi)
NZ (1) NZ237669A (fi)
PT (1) PT97355B (fi)
RU (1) RU2116346C1 (fi)
SA (1) SA92120348B1 (fi)
WO (1) WO1991016430A1 (fi)
ZA (1) ZA912489B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6784163B1 (en) * 1990-04-13 2004-08-31 Macleod Carol L. Inhibition of cationic amino acid transporter protein and uses thereof
WO1994004567A1 (en) * 1992-08-21 1994-03-03 La Jolla Cancer Research Foundation A matrix-associating dna-protein, nucleic acids encoding the same and methods for detecting the nucleic acids
US7138500B1 (en) 1993-05-07 2006-11-21 Immunex Corporation Antibodies to human 4-1BB
US7211259B1 (en) 1993-05-07 2007-05-01 Immunex Corporation 4-1BB polypeptides and DNA encoding 4-1BB polypeptides
WO1994026290A1 (en) * 1993-05-07 1994-11-24 Immunex Corporation Cytokine designated 4-1bb ligand and human receptor that binds thereto
US5866329A (en) * 1995-09-27 1999-02-02 Demetriou; Achilles A. Method and probe for detection of gene associated with liver neoplastic disease
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US6627199B1 (en) * 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
US20030096355A1 (en) * 1999-07-09 2003-05-22 Ke Zhang Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
AU6517800A (en) * 1999-08-04 2001-03-05 Amgen, Inc. Ntr3, a member of the tnf-receptor supergene family
EP1210435A1 (en) * 1999-08-04 2002-06-05 Amgen Inc. Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY
AU2002364889A1 (en) * 2001-09-24 2003-06-10 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
WO2007032717A1 (en) * 2005-08-03 2007-03-22 Astrazeneca Ab A method for identifying an agent that modulates arginine transport in a chondrocyte
WO2007056854A1 (en) * 2005-11-18 2007-05-24 University Health Network Method of expanding double negative t cells
AU2010258094B2 (en) * 2009-06-10 2013-09-05 Stephen Sanig Research Institute Ltd. Methods of generating cells exhibiting phenotypic plasticity

Also Published As

Publication number Publication date
FI108037B (fi) 2001-11-15
DE69121240D1 (de) 1996-09-12
DK0527813T3 (da) 1996-12-30
KR930700657A (ko) 1993-03-15
KR100212371B1 (ko) 1999-08-02
ATE141105T1 (de) 1996-08-15
GR3021478T3 (en) 1997-01-31
PT97355B (pt) 1998-08-31
EP0527813A4 (en) 1993-05-05
ZA912489B (en) 1992-01-29
US5440017A (en) 1995-08-08
HK1006726A1 (en) 1999-03-12
JPH05506989A (ja) 1993-10-14
CA2080018A1 (en) 1991-10-14
NO923918L (no) 1992-12-01
EP0527813A1 (en) 1993-02-24
DE69121240T2 (de) 1997-01-09
NO307341B1 (no) 2000-03-20
ES2093100T3 (es) 1996-12-16
AU664535B2 (en) 1995-11-23
US5312733A (en) 1994-05-17
WO1991016430A1 (en) 1991-10-31
IE911250A1 (en) 1991-10-23
IL97775A (en) 1998-04-05
IE75903B1 (en) 1997-10-08
EP0527813B1 (en) 1996-08-07
NZ237669A (en) 1992-08-26
CA2080018C (en) 2003-10-14
PT97355A (pt) 1991-12-31
IL97775A0 (en) 1992-06-21
AU7745791A (en) 1991-11-11
NO923918D0 (no) 1992-10-08
FI924575A0 (fi) 1992-10-09
RU2116346C1 (ru) 1998-07-27
SA92120348B1 (ar) 2004-01-24

Similar Documents

Publication Publication Date Title
FI924575A (fi) Nya t-cellymfom-cdna-kloner
RU2346951C2 (ru) Выделенный полипептид, связывающий рецептор zalpha11-лиганда (варианты), кодирующий его полинуклеотид (варианты), вектор экспрессии (варианты) и клетка-хозяин (варианты)
DE69535375D1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
DK1240337T3 (da) Fremgangsmåder og præparater til forlængelse af elimeneringshalveringstider af bioaktive forbindelser
DE3854952D1 (de) Mykobakterielle rekombinanten und peptide
EP0281604A4 (en) BINDING MOLECULES WITH SINGLE POLYPEPTIDE CHAIN.
DE69427997D1 (de) Hybrider mensch/tier faktor viii
EP0590071A4 (en) Substantially pure receptor like tgf--g(b)1 binding molecules and uses thereof
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
ATE83801T1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
HUP9802406A2 (hu) Oldható oligoszacharid-kötő doméneken alapuló elválasztó és töményítő rendszerek
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
ATE303437T1 (de) Rezeptor des ob-proteins und verwandte zusammensetzungen und verfahren
ATE247164T1 (de) Insulinartigen wachstumsfaktor bindendes protein
ATE190491T1 (de) Peptide als diagnose- und therapiemittel für spondyloarthropathien
ATE212056T1 (de) Methoden zur herstellung von rna viren aus cdna
ATE281519T1 (de) Klonierung und rekombinante herstellung des crf- rezeptors (crf=corticotropin ausloese faktor)
EP1905831A3 (en) Lactoferrin receptor genes of moraxella
MacLeod T-cell lymphoma CDNA clones

Legal Events

Date Code Title Description
MA Patent expired